Padcev (Enfortumab Vedotin-ejfv)

Padcev (enfortumab vedotin-ejfv) is a Nectin-4-directed antibody and microtubule inhibitor conjugate used:

• as a single agent for the treatment of adults with locally advanced or metastatic urothelial cancer who have previously been treated with programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and platinum-containing chemotherapy, or are ineligible for cisplatin-containing chemotherapy and have previously treated with one or more prior lines of therapy.
  
• along with medicine pembrolizumab to treat adults with locally advanced or metastatic urothelial cancer (mUC) who are not eligible for cisplatin-containing chemotherapy.

• Critical cutaneous side effects, including fatal cases of SJS or TEN, may occur in patients treated with Padcev injection. SJS and TEN may occur predominantly during the first cycle of treatment but may occur later. Monitor patients throughout treatment for skin reactions. Consider topical corticosteroids and antihistamines. 
  
• Hyperglycemia and diabetic ketoacidosis (DKA), including fatal events, may occur in patients with and without preexisting diabetes mellitus, treated with this drug. Closely monitor blood glucose levels in those with, or at risk for, diabetes mellitus or hyperglycemia. In case the blood glucose is increased (>250 mg/dL), withhold therapy.
  
• Serious, life-threatening, or fatal pneumonitis/ILD may occur in patients treated with Enfortumab vedotin-ejfv. Monitor patients for symptoms of pneumonitis/ILD such as cough, hypoxia, dyspnea, or interstitial infiltrates on radiologic exams. Assess and exclude infectious, neoplastic, and other causes for such symptoms through relevant investigations.
  
• Peripheral neuropathy may occur in patients treated with Enfortumab vedotin-ejfv as a single agent. Monitor patients for symptoms of new or worsening peripheral neuropathy and interrupt or reduce the dose when peripheral neuropathy occurs. Permanently stop treatment in patients who develop Grade >3 peripheral neuropathy.
  
• Ocular disorders may occur in patients treated with Padcev as a single agent. Ensure adequate venous access before starting treatment and monitor for possible extravasation during administration. In case extravasation occurs, stop the infusion and monitor for side effects.
  

Indian Pharma Network is able to source the PADCEV (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What documents are required to import PADCEV to India?

PADCEV (enfortumab vedotin-ejfv) injections can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patients ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
  
• Import permit if applicable

Is PADCEV available in India?

PADCEV (enfortumab vedotin-ejfv injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• Availability of padcev (Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka).
  
• Padcev available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow,  Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc
  
• Determining Medicine Price.
  
• Sourcing genuine and reliable sources from the USA, Canada, Europe, and Australia.
  
• Ensuring 100% transparency.

PADCEV can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Goa, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of PADCEV (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Padcev 20 mg/30 mg price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

What is the Generic Name for the trade name drug Padcev®?

Enfortumab vedotin-ejfv is a Generic Name for the trade name drug Padcev®.

What is the Manufacturer’s Name of Padcev®?

Padcev® is manufactured by Astellas Pharma US, Inc.

Is Padcev® approved by the FDA?

Yes, Padcev® is approved by the FDA. Date of first approval: December 18, 2019.

What is the dosage and form of Padcev® supplied?

Padcev® is supplied as injections: 20 mg and 30 mg of enfortumab vedotin-ejfv as a lyophilized powder in a single-dose vial for reconstitution for intravenous use.

How much does Padcev® cost in India?

The cost of Padcev in India can vary. To procure this therapeutic drug legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Padcev®?

Store Padcev® vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton. Avoid freezing and shaking the vials.

Is it safe to buy Padcev® online in India?

Yes, one can buy Padcev online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Padcev® through legal channels.

Where is padcev  available in India?

Padcev  available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow,  Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc